title: Tocilizumab increases EPC regeneration in rheumatoid arthritis.
authors.affiliation: Department of Nephrology and Rheumatology, University Hospital of Göttingen , Germany.
authors.forename: S
authors.initials: S
authors.lastname: Patschan
authors.forename: K
authors.initials: K
authors.lastname: Nemirovsky
authors.forename: E
authors.initials: E
authors.lastname: Henze
authors.forename: J
authors.initials: J
authors.lastname: Scholze
authors.forename: G A
authors.initials: GA
authors.lastname: Müller
authors.forename: D
authors.initials: D
authors.lastname: Patschan
mesh_terms: D000328:Adult; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D066026:Endothelial Progenitor Cells / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012038:Regeneration / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; C502936:tocilizumab